Silicon Biosystems, a subsidiary of Menarini Group, is a renowned brand that offers unique rare cell technologies and solutions. With their cutting-edge products and services, they provide clinical researchers with unparalleled resolution in the study of cells and their molecular characterization. Their impressive portfolio includes a range of products and services designed to meet the diverse needs of researchers.

They offer Cell Enrichment, Enumeration, and Sorting systems that enable researchers to isolate and analyze rare cells with single-cell precision. In the field of Molecular Characterization, their products and kits provide advanced tools for genomic analysis, library preparation, and NGS library preparation. Silicon Biosystems is dedicated to improving diagnostics and research in the field of oncology.

They have a comprehensive oncology portfolio that focuses on liquid biopsy for multiple myeloma, breast cancer, prostate cancer, colorectal cancer, and melanoma. With a strong commitment to quality and innovation, Silicon Biosystems is at the forefront of technological advancements in rare cell analysis. Partnering with them means gaining access to world-class solutions that drive breakthrough discoveries in the field of cell biology